Sean Khozin, a data science expert and formerly a senior medical officer at FDA, has been tapped to lead CancerLinQ—the American Society of Clinical Oncology’s multimillion-dollar big data initiative designed to generate real-world evidence from patient records.
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
